Finance
The history of Silicon Valley unicorn Theranos and CEO Elizabeth Holmes
Theranos’ star was shining bright going into 2015.
The darling blood-testing startup had racked up a $9 billion valuation with its big vision to test for a number of conditions off just a small sample of blood, and its CEO Elizabeth Holmes was featured on the cover of business magazines and lists of top executives. But then questions started being raised about how the company’s technology worked.
As Wall Street Journal reporter John Carreyrou details in his new book, “Bad Blood: Secrets and Lies in a Silicon Valley Startup,” the events leading up to the imminent downfall of the company started unraveling even years earlier. The book gives a behind the scenes look into the events propelled the biotech startup, Theranos, into chaos and deceit.
In June 2018, Holmes stepped down as CEO of Theranos, remaining with the company as a founder and chair of the board. She was also charged with wire fraud by the Department of Justice. On Tuesday, Theranos told investors that it was shutting down, The Wall Street Journal reported.
Here are the events that contributed to the rise, the fall, the pivot, and now criminal charges of the once promising company founded by Holmes.
-
Business5 days ago
Langdock raises $3M with General Catalyst to help businesses avoid vendor lock-in with LLMs
-
Entertainment5 days ago
What Robert Durst did: Everything to know ahead of ‘The Jinx: Part 2’
-
Entertainment5 days ago
This nova is on the verge of exploding. You could see it any day now.
-
Business5 days ago
India’s election overshadowed by the rise of online misinformation
-
Business4 days ago
This camera trades pictures for AI poetry
-
Business5 days ago
CesiumAstro claims former exec spilled trade secrets to upstart competitor AnySignal
-
Business7 days ago
Screen Skinz raises $1.5 million seed to create custom screen protectors
-
Entertainment6 days ago
Dating culture has become selfish. How do we fix it?